All Articles

Eason Technology leadership's big share purchase signals confidence. But with declining revenue and a "going concern" warning, is this a bet on a real turnaround?

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

A new European patent grants WISeKey the power to embed NFTs into physical chips, creating an unforgeable, quantum-proof link between art and its identity.

Industrial arm maker INLIF is jumping into the humanoid race. But can a small firm with unverified claims compete with giants like Boston Dynamics and Tesla?

Perion's new 'Ask Perion' AI aims to automate ad campaigns. But does this self-serve model truly empower marketers or just boost Perion's bottom line?

E-commerce brands are drowning in fragmented data. A new partnership between Shirofune and Triple Whale offers a single source of truth to automate ad optimization.

A new survey reveals half of Americans feel a summer cash crunch, but for Gen Z, it's a crisis forcing drastic measures, from 60-hour weeks to new digital frontiers.

A new firm, Nortiva Bio, is launching with tech from MIT to turn daily pills into monthly doses, starting with a contraceptive backed by the Gates Foundation.

A new partnership between Charles River and Lilly TuneLab merges AI with nonclinical testing, aiming to fast-track new medicines and level the field for biotechs.

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

Companies like eGenesis are turning science fiction into reality with gene-edited pig organs. This is the story of a medical revolution at a crossroads.

Seven years ago, 'Global Warning' was dismissed as a niche documentary. Today, its director claims it's the key to Canada's future. What changed?

As AI gets more powerful, the human user is becoming the bottleneck. A new class of 'Super-Sub' AI assistants aims to fix this by streamlining our workflow.

Beyond simple comfort, your next HVAC is a major investment. We break down the tech, costs, and policies shaping the heat pump, furnace, and hybrid debate.

Opodo's latest data reveals more than just destinations; it shows a strategic consumer shift. Brits are trading long-haul for value and impulse for planning.

New detachable sensor leads from Monnit allow for instant recertification, eliminating costly downtime in pharma and healthcare while ensuring data integrity.

A court ruling clears the way for Curium's targeted cancer drug, promising new hope for patients and shaking up the multi-billion-dollar radiopharmaceutical market.

A new report reveals a startling trend: as AI adoption soars, financial firms are increasingly banning communication channels, a defensive move creating new risks.

Parke Bancorp's dividend increase is more than just a number. It's a story of local focus, disciplined growth, and what it takes to thrive in today's economy.

Beyond the ribbon-cutting, Healthconnect Texas's new hub is the physical anchor for an ambitious plan to merge clinical and social data, reshaping care for 27M.